Form 4: Hayward Holdings CEO Kevin Holleran Executes Stock Option and Sells Shares

Sentiment:

SEC Form 4 Filing


Kevin Holleran, President and CEO of Hayward Holdings, exercised stock options and sold 42,857 shares of common stock on April 17, 2024.

Summary

  • On April 17, 2024, Kevin Holleran, the President and CEO of Hayward Holdings, exercised stock options to acquire 42,857 shares of common stock at a price of $1.40 per share.
  • Simultaneously, Holleran sold 42,857 shares of common stock at a weighted average price of $13.3443, with individual sales ranging from $13.27 to $13.53.
  • Following these transactions, Holleran directly owns 522,799 shares of Hayward Holdings common stock.
  • He also indirectly owns 700 shares each through Child A, Child B, and Child C.
  • Holleran continues to hold options to purchase 3,552,856 shares of common stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions and doesn't necessarily reflect broader industry trends. However, it's common for executives to exercise stock options and sell shares for personal financial management.

Comparison to Industry Standards

  • Executive compensation packages often include stock options as a form of long-term incentive.
  • The exercise and sale of shares by executives are common and are typically disclosed through Form 4 filings with the SEC.
  • The specific details of the option grants and vesting schedules vary from company to company.

Stakeholder Impact

  • The transaction may have a minor impact on shareholders due to the increase in the number of shares available in the market.
  • The transaction provides insight into the executive's personal financial decisions, but it doesn't necessarily reflect the company's overall performance or strategy.

Key Dates

DateDescription
04/17/2024Date of stock option exercise and share sale.
04/18/2024Date of signature for the Form 4 filing.
12/24/2029Expiration date of the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.